Lamotrigine Tablet
Product Images NDC 71205-245

6 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 71205-245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (1f54285f 566c 4e96 867e 4e8dfdd3340a 01)

Molecular Structure (1f54285f 566c 4e96 867e 4e8dfdd3340a 01)
Chemical structure of lamotrigine showing a triazine ring with amino substituents and a chlorinated phenyl ring attached. The diagram depicts the molecular configuration with chlorine and amino groups clearly indicated.*
FDA Label Image

Figure 1 (1f54285f 566c 4e96 867e 4e8dfdd3340a 02)

Figure 1 (1f54285f 566c 4e96 867e 4e8dfdd3340a 02)
A Kaplan-Meier curve showing failure probability (%) over time in weeks for patients treated with Lamotrigine versus placebo. The graph plots the cumulative probability of failure with separate labeled curves for Lamotrigine and placebo, including censored data points marked with plus signs.*
FDA Label Image

Figure 2 (1f54285f 566c 4e96 867e 4e8dfdd3340a 03)

Figure 2 (1f54285f 566c 4e96 867e 4e8dfdd3340a 03)
A Kaplan-Meier failure probability plot showing the percentage of patients experiencing failure over time in weeks. The graph compares two groups: Placebo and Lamotrigine, with Placebo showing a higher failure probability over time. The chart includes censored data marked on the curves.*
FDA Label Image

Tablet Pictorial View (1f54285f 566c 4e96 867e 4e8dfdd3340a 04)

Tablet Pictorial View (1f54285f 566c 4e96 867e 4e8dfdd3340a 04)
Lamotrigine tablets in various strengths and colors as shown in the image. The 25 mg tablet is white and oval-shaped with imprint 'U 111'. The 100 mg tablet is white and triangular with imprint 'U 112'. The 150 mg tablet is white and triangular with imprints 'U' and '113' on one piece and 'U' on the other. The 200 mg tablet is light blue and triangular with imprints 'U' and '114' on one piece and 'U' on the other, labeled by Proficient Rx LP.*
FDA Label Image

Logo (1f54285f 566c 4e96 867e 4e8dfdd3340a 05)

FDA Label Image

71205-245-30 (1f54285f 566c 4e96 867e 4e8dfdd3340a 07)

71205-245-30 (1f54285f 566c 4e96 867e 4e8dfdd3340a 07)
Lamotrigine 100 mg tablets packaging label from Proficient Rx LP. The label shows a 30-tablet count with details that each scored tablet contains 100 mg of lamotrigine, USP. Tablets are described as white, trigonal shaped, biconvex with 'U' and '112' debossed. Manufactured by Unichem Laboratories Ltd in India. Storage instructions are 20°-25°C (68°-77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.